Lenka Polakova
Overview
Explore the profile of Lenka Polakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sobotka O, Ticha M, Kubickova M, Adamek P, Polakova L, Mezera V, et al.
Nutrients
. 2023 Jan;
15(2).
PMID: 36678311
Carbohydrate (CHO) intake in oral and enteral nutrition is regularly reduced in nutritional support of older patients due to the high prevalence of diabetes (usually type 2-T2DM) in this age...
2.
Polakova L, Raus V, Cuchalova L, Poreba R, Hruby M, Kucka J, et al.
Int J Pharm
. 2021 Dec;
613:121392.
PMID: 34933083
Inflammatory bowel disease (IBD) is a relapsing and remitting inflammatory disease affecting millions of people worldwide. The active phase of IBD is characterized by excessive formation of reactive oxygen species...
3.
Groborz O, Polakova L, Kolouchova K, Svec P, Loukotova L, Miriyala V, et al.
Macromol Biosci
. 2020 Sep;
20(12):e2000254.
PMID: 32954629
Hemochromatosis (iron overload) encompasses a group of diseases that are characterized by a toxic hyperaccumulation of iron in parenchymal organs. Currently, only few treatments for this disease have been approved;...
4.
Rabie F, Polakova L, Fallas S, Sedlakova Z, Marand E, Martin S
Membranes (Basel)
. 2019 Aug;
9(8).
PMID: 31434248
Stable, cross-linked, liquid crystalline polymer (LCP) films for membrane separation applications have been fabricated from the mesogenic monomer 11-(4-cyanobiphenyl-4'-yloxy) undecyl methacrylate (CNBPh), non-mesogenic monomer 2-ethylhexyl acrylate (2-EHA), and cross-linker ethylene...
5.
Polakova L, Sirc J, Hobzova R, Cocarta A, Hermankova E
Int J Pharm
. 2019 Jan;
558:268-283.
PMID: 30611748
Currently, chemotherapy is the most common treatment for oncological diseases. Systemic administration of chemotherapeutics provides an easy and effective distribution of the active agents throughout the patient's body, however organs...
6.
Hermankova E, Zak A, Polakova L, Hobzova R, Hromadka R, Sirc J
Eur J Med Chem
. 2017 Dec;
144:300-317.
PMID: 29275230
Polymeric bile acid sequestrants (BAS) have recently attracted much attention as lipid-lowering agents. These non-absorbable materials specifically bind bile acids (BAs) in the intestine, preventing bile acid (BA) reabsorption into...